February 25, 2025 - 11:52

Alvin F. Poussaint, a renowned psychiatrist and influential advocate for Black mental health, has passed away at the age of 90. His groundbreaking work at Harvard University and his role as an adviser to prominent figures such as Jesse Jackson and Bill Cosby have left an indelible mark on the field of mental health. Poussaint was a vocal advocate for addressing the psychological impacts of systemic racism on the Black community.
Throughout his career, he emphasized the importance of mental well-being and encouraged Black Americans to confront the challenges posed by societal inequities. His commitment to mental health education and advocacy helped to dismantle stigmas surrounding mental illness within the African American community. Poussaint's legacy includes not only his clinical contributions but also his ability to inspire a generation of individuals to prioritize mental health and fight against racial injustice. His passing is a significant loss to the field and to all who benefited from his insights and dedication.
 
                November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
 
                October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
 
                October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
 
                October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...